TGFB1 and diabetes mellitus: In addition, use of an anti-TGF-β1 neutralizing antibody to block TGF-β/Smad3 signaling protects mice from obesity, diabetes, and hepatic steatosis (Tan et al., 2011; Yadav et al., 2011).